Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 208811
Company: MYLAN INSTITUTIONAL
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
FULVESTRANT FULVESTRANT 50MG/ML INJECTABLE;INTRAMUSCULAR Prescription AO No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/23/2019 ORIG-1 Approval STANDARD

Label is not available on this site.

FULVESTRANT

INJECTABLE;INTRAMUSCULAR; 50MG/ML
TE Code = AO

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
FASLODEX FULVESTRANT 50MG/ML INJECTABLE;INTRAMUSCULAR Prescription Yes AO 021344 ASTRAZENECA
FULVESTRANT FULVESTRANT 50MG/ML INJECTABLE;INTRAMUSCULAR Prescription No AO 210044 AMNEAL
FULVESTRANT FULVESTRANT 50MG/ML INJECTABLE;INTRAMUSCULAR Prescription No AO 207754 GLENMARK PHARMS INC
FULVESTRANT FULVESTRANT 50MG/ML INJECTABLE;INTRAMUSCULAR Prescription No AO 208811 MYLAN INSTITUTIONAL
FULVESTRANT FULVESTRANT 50MG/ML INJECTABLE;INTRAMUSCULAR Prescription No AO 205871 SAGENT PHARMS INC
FULVESTRANT FULVESTRANT 50MG/ML INJECTABLE;INTRAMUSCULAR Prescription No AO 205935 SANDOZ INC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English